Genome Sequence of Bordetella pertussis Vaccine Strain BP 165

Shweta Alai; Vikas C Ghattargi; Manish Gautam; Dhiraj P Dhotre; Krunal Patel; Shrikant P Pawar; Rakesh Kumar; Umesh Shaligram; Deepti Deobagkar; Sunil Gairola

doi:10.1128/MRA.00150-19

Genome Sequence of Bordetella pertussis Vaccine Strain BP 165

Microbiol Resour Announc. 2019 Apr 18;8(16):e00150-19. doi: 10.1128/MRA.00150-19.

Authors

Affiliations

¹ Department of Health and Biological Sciences, Symbiosis International University, Pune, Maharashtra, India.
² National Centre for Microbial Resource, National Centre for Cell Science, Pune, Maharashtra, India.
³ Serum Institute of India Private Limited, Pune, Maharashtra, India.
⁴ ISRO Space and Technology Cell and Molecular Research Laboratory, Department of Zoology, Savitribai Phule Pune University, Pune, Maharashtra, India.
⁵ Serum Institute of India Private Limited, Pune, Maharashtra, India sunil.gairola@seruminstitute.com.

Abstract

Whole-cell and acellular pertussis vaccines are used globally against Bordetella pertussis Various vaccine reference strains are used globally for the production of such vaccines. We report here a draft genome sequence for Bordetella pertussis strain BP 165, which is used by the Serum Institute of India in the production of acellular pertussis vaccine.